New alteration in the brains of people with Alzheimer's discovered

by Spanish National Research Council (CSIC)Credit: Unsplash/CC0 Public DomainDespite the important advances in research in recent years, the etiopathogenesis of Alzheimer's disease is still not fu

Updated on: April 20,2024

New alteration in the brains of people with Alzheimer's discovered

by Spanish National Research Council (CSIC)Credit: Unsplash/CC0 Public DomainDespite the important advances in research in recent years, the etiopathogenesis of Alzheimer's disease is still not fu

Updated on:April 20,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on: April 01,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on:April 01,2024

Not just a 'bad guy': Researchers discover neuroprotective function of Tau protein

by Rajalaxmi Natarajan,Baylor College of MedicineOverexpression of hTau in glia disrupts LDs and glial cell morphology in response to neuronal ROS. Credit:Nature Neuroscience(2024).

Updated on: September 06,2024

Not just a 'bad guy': Researchers discover neuroprotective function of Tau protein

by Rajalaxmi Natarajan,Baylor College of MedicineOverexpression of hTau in glia disrupts LDs and glial cell morphology in response to neuronal ROS. Credit:Nature Neuroscience(2024).

Updated on:September 06,2024

Understanding genetic risk could save sight and predict multiple sclerosis earlier in young people

byUniversity of ExeterCredit: CC0 Public DomainYoung people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start ef

Updated on: April 22,2024

Understanding genetic risk could save sight and predict multiple sclerosis earlier in young people

byUniversity of ExeterCredit: CC0 Public DomainYoung people could be spared from going blind by a new genetic risk tool that could also help diagnose multiple sclerosis (MS) earlier, to start ef

Updated on:April 22,2024

How does the brain keep calm? Insight into brain stability and the key role of NMDA receptors

byTel-Aviv UniversityGraphical abstract. Credit:Neuron(2024). DOI: 10.1016/j.neuron.2024.10.014Researchers at Tel Aviv University have made a fundamental discovery: the NMDA receptor

Updated on: November 28,2024

How does the brain keep calm? Insight into brain stability and the key role of NMDA receptors

byTel-Aviv UniversityGraphical abstract. Credit:Neuron(2024). DOI: 10.1016/j.neuron.2024.10.014Researchers at Tel Aviv University have made a fundamental discovery: the NMDA receptor

Updated on:November 28,2024

Researchers identify three genes associated with neurodevelopmental disorders

by Children's Hospital of PhiladelphiaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI171235An international study group led by researchers of

Updated on: June 19,2024

Researchers identify three genes associated with neurodevelopmental disorders

by Children's Hospital of PhiladelphiaGraphical abstract. Credit:Journal of Clinical Investigation(2023). DOI: 10.1172/JCI171235An international study group led by researchers of

Updated on:June 19,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on: April 16,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on:April 16,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on: March 30,2024

First 'gene silencing' drug for Alzheimer's disease shows promise

by University College LondonEffect of MAPTRxon CSF concentrations of p-tau protein and tau/Aβ42. a, The mean percentage change from baseline in p-tau over time according to dose group. b, T

Updated on:March 30,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on: May 20,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on:May 20,2024

Healthy diet may reduce cognitive decline as people age

by Karolinska InstitutetEating healthier may reduce cognitive decline and diminish the negative impact of an unhealthy diet on memory and thinking abilities in older adults, suggests a new study

Updated on: February 26,2024

Healthy diet may reduce cognitive decline as people age

by Karolinska InstitutetEating healthier may reduce cognitive decline and diminish the negative impact of an unhealthy diet on memory and thinking abilities in older adults, suggests a new study

Updated on:February 26,2024

Disruption of brain-blood barrier might influence progression of Alzheimer's

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.More and more data from preclinical and clinical st

Updated on: February 26,2024

Disruption of brain-blood barrier might influence progression of Alzheimer's

by VIB (the Flanders Institute for Biotechnology)Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.More and more data from preclinical and clinical st

Updated on:February 26,2024

New biomarker for dementia diagnosis

by Flinders UniversityProfessor Arduino Mangoni, Head of Clinical Pharmacology at Flinders University, in his research laboratory in South Australia. Credit: Flinders UniversityMedical researcher

Updated on: May 11,2024

New biomarker for dementia diagnosis

by Flinders UniversityProfessor Arduino Mangoni, Head of Clinical Pharmacology at Flinders University, in his research laboratory in South Australia. Credit: Flinders UniversityMedical researcher

Updated on:May 11,2024